FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149469425> ?p ?o ?g. }

• W2149469425 endingPage "625" @default.
• W2149469425 startingPage "620" @default.
• W2149469425 abstract "A multicenter, prospective randomized trial was conducted to determine if the addition of rifampin to a combination therapy of an antipseudomonal beta-lactam agent and aminoglycoside improves the outcome of patients with Pseudomonas aeruginosa bacteremia. The Zelen protocol for randomized-consent design was used. Consent was sought only from patients randomized to the experimental therapy (rifampin+). If the experimental therapy was refused, the patient would then receive the standard combination therapy (control); however, when outcome was evaluated, all patients randomized to the rifampin+ group, including those that declined rifampin, were compared with the control group. One hundred twenty-one consecutive hospitalized patients with positive blood cultures for P. aeruginosa were enrolled. Entry was stratified for prior use of empiric antipseudomonal antibiotics, neutropenia, severity of illness, and presence of pneumonia. Fifty-eight patients were randomized to receive rifampin (600 mg orally every 8 h for the first 72 h and then every 12 h for a total of 10 days) plus a beta-lactam agent plus an aminoglycoside. Sixty-three received the standard therapy of a beta-lactam plus an aminoglycoside agent (control). Bacteriologic cure occurred significantly more frequently in patients randomized to the rifampin+ regimen. Breakthrough or relapsing bacteremias occurred in 2% of the three-drug (rifampin+) group, compared with 14% for the two-drug (standard therapy) group. Despite this favorable trend in bacteriological response, no significant differences in survival were seen for the two treatment groups. Rifamycin derivatives warrant further clinical study as antipseudomonal agents. The Zelen protocol appears well suited for comparative trials of antimicrobial agents." @default.
• W2149469425 created "2016-06-24" @default.
• W2149469425 creator A5028463782 @default.
• W2149469425 creator A5033762962 @default.
• W2149469425 creator A5071678716 @default.
• W2149469425 creator A5073166650 @default.
• W2149469425 creator A5073539991 @default.
• W2149469425 date "1992-03-01" @default.
• W2149469425 modified "2023-09-27" @default.
• W2149469425 title "Addition of rifampin to combination antibiotic therapy for Pseudomonas aeruginosa bacteremia: prospective trial using the Zelen protocol" @default.
• W2149469425 cites W1576273939 @default.
• W2149469425 cites W1969880158 @default.
• W2149469425 cites W1975383446 @default.
• W2149469425 cites W1980043956 @default.
• W2149469425 cites W1988653216 @default.
• W2149469425 cites W1996490500 @default.
• W2149469425 cites W2001466345 @default.
• W2149469425 cites W2021486586 @default.
• W2149469425 cites W2025801951 @default.
• W2149469425 cites W2039385490 @default.
• W2149469425 cites W2049448659 @default.
• W2149469425 cites W2054676739 @default.
• W2149469425 cites W2060321213 @default.
• W2149469425 cites W2074570941 @default.
• W2149469425 cites W2077074905 @default.
• W2149469425 cites W2087056834 @default.
• W2149469425 cites W2088671785 @default.
• W2149469425 cites W2089340768 @default.
• W2149469425 cites W2092184888 @default.
• W2149469425 cites W2137749172 @default.
• W2149469425 cites W2159209454 @default.
• W2149469425 cites W2320473396 @default.
• W2149469425 cites W2341550006 @default.
• W2149469425 cites W2417417070 @default.
• W2149469425 cites W2104493016 @default.
• W2149469425 cites W2439503167 @default.
• W2149469425 cites W2607012704 @default.
• W2149469425 doi "https://doi.org/10.1128/aac.36.3.620" @default.
• W2149469425 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/190567" @default.
• W2149469425 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1622173" @default.
• W2149469425 hasPublicationYear "1992" @default.
• W2149469425 type Work @default.
• W2149469425 sameAs 2149469425 @default.
• W2149469425 citedByCount "47" @default.
• W2149469425 countsByYear W21494694252012 @default.
• W2149469425 countsByYear W21494694252013 @default.
• W2149469425 countsByYear W21494694252016 @default.
• W2149469425 countsByYear W21494694252020 @default.
• W2149469425 crossrefType "journal-article" @default.
• W2149469425 hasAuthorship W2149469425A5028463782 @default.
• W2149469425 hasAuthorship W2149469425A5033762962 @default.
• W2149469425 hasAuthorship W2149469425A5071678716 @default.
• W2149469425 hasAuthorship W2149469425A5073166650 @default.
• W2149469425 hasAuthorship W2149469425A5073539991 @default.
• W2149469425 hasBestOaLocation W21494694251 @default.
• W2149469425 hasConcept C126322002 @default.
• W2149469425 hasConcept C141071460 @default.
• W2149469425 hasConcept C168563851 @default.
• W2149469425 hasConcept C2776694085 @default.
• W2149469425 hasConcept C2776999253 @default.
• W2149469425 hasConcept C2777063308 @default.
• W2149469425 hasConcept C2777637488 @default.
• W2149469425 hasConcept C2777787772 @default.
• W2149469425 hasConcept C2777914695 @default.
• W2149469425 hasConcept C2779443120 @default.
• W2149469425 hasConcept C2781413609 @default.
• W2149469425 hasConcept C501593827 @default.
• W2149469425 hasConcept C523546767 @default.
• W2149469425 hasConcept C54355233 @default.
• W2149469425 hasConcept C71924100 @default.
• W2149469425 hasConcept C86803240 @default.
• W2149469425 hasConcept C89423630 @default.
• W2149469425 hasConceptScore W2149469425C126322002 @default.
• W2149469425 hasConceptScore W2149469425C141071460 @default.
• W2149469425 hasConceptScore W2149469425C168563851 @default.
• W2149469425 hasConceptScore W2149469425C2776694085 @default.
• W2149469425 hasConceptScore W2149469425C2776999253 @default.
• W2149469425 hasConceptScore W2149469425C2777063308 @default.
• W2149469425 hasConceptScore W2149469425C2777637488 @default.
• W2149469425 hasConceptScore W2149469425C2777787772 @default.
• W2149469425 hasConceptScore W2149469425C2777914695 @default.
• W2149469425 hasConceptScore W2149469425C2779443120 @default.
• W2149469425 hasConceptScore W2149469425C2781413609 @default.
• W2149469425 hasConceptScore W2149469425C501593827 @default.
• W2149469425 hasConceptScore W2149469425C523546767 @default.
• W2149469425 hasConceptScore W2149469425C54355233 @default.
• W2149469425 hasConceptScore W2149469425C71924100 @default.
• W2149469425 hasConceptScore W2149469425C86803240 @default.
• W2149469425 hasConceptScore W2149469425C89423630 @default.
• W2149469425 hasIssue "3" @default.
• W2149469425 hasLocation W21494694251 @default.
• W2149469425 hasLocation W21494694252 @default.
• W2149469425 hasLocation W21494694253 @default.
• W2149469425 hasOpenAccess W2149469425 @default.
• W2149469425 hasPrimaryLocation W21494694251 @default.
• W2149469425 hasRelatedWork W1988161935 @default.
• W2149469425 hasRelatedWork W2087965715 @default.
• W2149469425 hasRelatedWork W2090711804 @default.

• next